More than 40% of cancer drugs granted accelerated approval from 2013 to 2017 did not demonstrate clinical benefit in confirmatory trials, according to a study in the Journal of the American Medical Association (JAMA). The paper ‘Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated… Read More
On the final day of AACR, the plenary session of the Annual Meeting put artificial intelligence at the forefront and featured a stellar lineup of AI and data science experts who discussed AI and topics such as imaging, precision medicine, and drug development. The closing plenary… Read More
Today, National Cancer Institute leaders discussed cancer breakthroughs and the importance of securing support from lawmakers for the NCI and National Institutes of Health in the session ‘The Cancer Moonshot: Opportunities to Fulfill the Vision of the National Cancer Plan – Dedicated to the Memory of Sen. Dianne… Read More
A round-up of the latest news from the American Association of Cancer Research (AACR) Annual Meeting. Symposiums UCLA: Dr Zev Wainberg, Co-Director of the UCLA Health GI Oncology Program, presented results from pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators, which suggests that for… Read More
The American Association of Cancer Research (AACR) Annual Meeting launched on Sunday 7 April in San Diego with an Opening Plenary Session showcasing cutting-edge technological advances opening new frontiers in cancer science. The session ‘Inspiring Science, Fueling Progress, Revolutionizing Care’ featured a distinguished panel of cancer… Read More
Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments. The study was led by the Science and Technology Facilities Council (STFC) Central Laser Facility (CLF) and used advanced… Read More
While the age-adjusted overall cancer death rate in the US fell by 33% between 1991 and 2020, cancer remains a significant threat to human health, with more than two million new cases expected to be diagnosed in 2024 and uneven progress across different cancer types1. These… Read More
Curve Therapeutics’ CSO Ali Tavassoli has published an article in the Journal of the American Chemical Society (JACS) which highlights the potential of HIF inhibition as a therapeutic approach for cancers. The paper is titled ‘Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors (HIF) 1 and… Read More
This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More
Bio-Rad Laboratories has launched validated antibodies for rare cell and circulating tumour cell (CTC) enumeration for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits. The antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of… Read More
Created by DDW and sponsored by HUB Organoids, ‘Oncology research: Where are the breakthroughs and innovation?’ is a free In Focus report now available to download. Oncology represents the drug discovery and development sector’s biggest focus area and whilst novel treatments continue to emerge… Read More
Download this exclusive DDW eReport to learn more about: Oncology drug discovery and development: A market overview The technologies and therapeutic approaches that will drive the future of cancer drug discovery Oncology, drug discovery and the potential of organoids The research driving advancements in oncology and recent approvals in the sector… Read More
This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More
Download this exclusive DDW eReport to learn more about: Oncology drug discovery and development: A market overview The technologies and therapeutic approaches that will drive the future of cancer drug discovery Oncology,… Read More
This is the latest episode of the free DDW narrated podcast, titled “Flow cytometry for drug discovery research” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Flow cytometry technologies and cancer associated fibroblasts and Leveraging… Read More
CureLab Oncology’s DNA vaccine Elenagen, in combination with chemotherapy, has demonstrated promising clinical results against triple-negative ovarian cancer. The study shows that disease progression was significantly delayed in a group of stage III and IV platinum-resistant ovarian cancer (PROC) patients who received gemcitabine in combination with… Read More
